drugset / Trial / NCT01181167

A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

NCT01181167

Phase 3 Completed 610 enrolled Daiichi Sankyo
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The objective of this study is to assess the efficacy and safety of DU-176b compared with enoxaparin sodium for the prevention of venous thromboembolism in patients after elective total hip arthroplasty.

Timeline

Start
2009-05
Primary completion
2010-01
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Edoxaban Small molecule 30 mg Oral
Comparator Enoxaparin sodium Other / unclassified 20 mg Subcutaneous